Article
Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionucleotide Therapy for Glioblastoma
2024-07-09
Abstract excerpt
<h4>Background: </h4> Glioblastoma (GBM) is a highly aggressive, invasive, and growth-factor-independent grade IV glioma. Survival following the diagnosis is generally poor, with a median survival of approximately 15 months, and it is considered the most aggressive and lethal central nervous system tumor. Conventional treatments based on surgery, chemotherapy, and radiation therapy only delay progression, and deat...
Topics
Open a Topic to create a Post that cites this publication.
- bioluminescence and chemiluminescence research
- Cancer Research and Treatments
- Medical Imaging Techniques and Applications
- Neuroblastoma Research and Treatments
- Radiopharmaceutical Chemistry and Applications
- Thyroid Cancer Diagnosis and Treatment
- Viral gastroenteritis research and epidemiology
- Virus-based gene therapy research
Identifiers and source
- Literature Corpus work
- 6e5f2cf0-c79a-5dcd-a6ab-169a2d86b5a6
- DOI
- 10.20944/preprints202407.0690.v1
